title: Sequential Optical Coherence Tomographic Angiography for Diagnosis and Treatment of Choroidal Neovascularization in Multifocal Choroiditis.
authors.affiliation: New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts2Vitreoretinal Service, Tufts Medical Center, Tufts University, Boston, Massachusetts.
authors.forename: Caroline R
authors.initials: CR
authors.lastname: Baumal
authors.affiliation: New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts2Vitreoretinal Service, Tufts Medical Center, Tufts University, Boston, Massachusetts3Department of Electrical Engineering and Computer Science, Massachusetts Institute of T.
authors.forename: Talisa E
authors.initials: TE
authors.lastname: de Carlo
authors.affiliation: New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts2Vitreoretinal Service, Tufts Medical Center, Tufts University, Boston, Massachusetts.
authors.forename: Nadia K
authors.initials: NK
authors.lastname: Waheed
authors.affiliation: New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts2Vitreoretinal Service, Tufts Medical Center, Tufts University, Boston, Massachusetts.
authors.forename: David A
authors.initials: DA
authors.lastname: Salz
authors.affiliation: New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts2Vitreoretinal Service, Tufts Medical Center, Tufts University, Boston, Massachusetts.
authors.forename: Andre J
authors.initials: AJ
authors.lastname: Witkin
authors.affiliation: New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts2Vitreoretinal Service, Tufts Medical Center, Tufts University, Boston, Massachusetts.
authors.forename: Jay S
authors.initials: JS
authors.lastname: Duker
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D002833:Choroiditis / Q000150:complications* / Q000503:physiopathology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D000080364:Multifocal Choroiditis; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab